Abbott Laboratories (ABT) — Hedge Fund Ownership Q1 2026
ABT
- Abbott Laboratories (ABT) is held by 6 of 84 tracked hedge funds, with Jensen Investment Management (3%) and Maverick Capital (2%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- New position in ABT stock was initiated by Maverick Capital (2%).
- The biggest increases in ABT holdings came from Mairs & Power (+2%), highlighting conviction.
- The biggest decreases in ABT holdings came from Polen Capital Management (-100%) and Jensen Investment Management (-21%), suggesting profit-taking or de-risking.
- 1 hedge fund exited ABT.
- Overall, hedge funds decreased exposure to Abbott Laboratories (ABT) by -66% vs the prior quarter and -84% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Jensen Investment Management
|
3.01% | 1.5M | -20.66% | +8.80% | $152.6M | $102.67 | — |
| 2 |
Maverick Capital Lee Ainslie
|
2.10% | 1.8M | NEW | — | $180.5M | $102.67 | — |
| 3 |
Mairs & Power
|
0.76% | 722K | +1.93% | -29.03% | $74.1M | $102.67 | — |
| 4 |
Gardner Russo & Quinn Thomas Russo
|
0.01% | 12K | — | — | $1.2M | $102.67 | — |
| 5 |
Polen Capital Management
|
0.01% | 15K | -99.62% | -99.87% | $1.5M | $102.67 | — |
| 6 |
Dodge & Cox
|
0.00% | 17K | — | — | $1.8M | $102.67 | — |
| — |
Torray Investment Partners Robert Torray
|
— | — | EXITED | — | — | — | — |
| 6 | Total | — | 4.0M | -65.75% | -83.68% | $411.7M | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.